Question

"A student is writing an argument to support the claim that prescription drug prices should be regulated by law. Which point should be included in the concluding argument? Select the two correct answers. (1 point) Responses Drug prices that are beyond reach for those who rely on these drugs are a very serious public health issue. Drug prices that are beyond reach for those who rely on these drugs are a very serious public health issue. It’s also important to mention that nearly one-third of patients do not take medication as directed because of its cost. It’s also important to mention that nearly one-third of patients do not take medication as directed because of its cost. Per a recent poll, 35 percent of Americans taking four or more prescription drugs had difficulty paying for their medication. Per a recent poll, 35 percent of Americans taking four or more prescription drugs had difficulty paying for their medication. A lack of transparency in drug prices hurts doctors and the medical community, as well as patients and their families. A lack of transparency in drug prices hurts doctors and the medical community, as well as patients and their families. If an effective universal health care program were adopted, then there would be no need to regulate drug prices. If an effective universal health care program were adopted, then there would be no need to regulate drug prices. Skip to navigation"

Answer 1

The two points that should be included in the concluding argument to support the claim that prescription drug prices should be regulated by law are:

1. **Drug prices that are beyond reach for those who rely on these drugs are a very serious public health issue.**
This point emphasizes the direct impact of high drug prices on public health, highlighting the necessity for regulation to ensure access to essential medications.

2. **Per a recent poll, 35 percent of Americans taking four or more prescription drugs had difficulty paying for their medication.**
This statistic provides concrete evidence of the financial burden faced by many patients, reinforcing the argument that regulation is needed to address this issue.

Both of these points strengthen the argument by addressing the consequences of high drug prices and providing factual evidence of the problem.